prof. MUDr. Mgr. Marek Mráz, Ph.D.
Research Group Leader Senior, Marek Mráz Research Group
Office: bldg. E35/216
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8143 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 266
2018
-
CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo
Year: 2018, type: Conference abstract
-
Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience
Year: 2018, type: Conference abstract
-
Genetické aberace a doba do progrese onemocnění u pacientů s CLL léčených režimy FCR nebo BR v 1. linii
Year: 2018, type: Conference abstract
-
Inovativní inhibitor proteinu CHK1 indukuje apoptózu u buněk chronické lymfocytární leukémie s mutacemi v genu TP53
Year: 2018, type: Conference abstract
-
Microenvironmental interactions in malignant B cells: from biological mechanisms to better targeted therapies
Year: 2018, type:
-
Microenvironmental interactions in mature B cell malignancies: combinatorial strategies of targeted therapy
Year: 2018, type:
-
microRNA – are you real?
Year: 2018, type: Conference abstract
-
MicroRNAs contribute to high-grade transformation of follicular lymphoma
Year: 2018, type:
-
miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels
Blood, year: 2018, volume: 132, edition: 22, DOI
-
MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma by upregulating FOXP1 levels
Year: 2018, type: Conference abstract